CLINICAL VALIDATION OF FLOW CYTOMETRY 10 COLOR PANEL FOR ASSESSMENT OF MEASURABLE RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA

CLINICAL VALIDATION OF FLOW CYTOMETRY 10 COLOR PANEL FOR ASSESSMENT OF MEASURABLE RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA

Given the usefulness of measurable residual disease (MRD) in evaluating treatment efficacy and to predict relapse, MRD monitoring is becoming more frequent for the management of patients with acute myeloid leukemia (AML). Therefore, the accuracy of the methods is essential to obtain reliable results...

Full description

Saved in:
Bibliographic Details
Main Authors: MRV Ikoma-Colturato, AR Severino, JFDS Tosi, CM Bertolucci, I Colturato, FBR Silva, ER Mattos, MP Souza, AJ Simione, VAR Colturato
Format: Article
Language:English
Published: Elsevier 2024-10-01
Series:Hematology, Transfusion and Cell Therapy
Online Access:http://www.sciencedirect.com/science/article/pii/S2531137924009441
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items